🚀 VC round data is live in beta, check it out!

Largest BioTech Public Companies in Hong Kong

Benchmark revenue and EBITDA valuation multiples for public comps like
Sino Biopharmaceutical and Regencell Bioscience.

Select Vertical

Select Theme

Select Country


Sino Biopharmaceutical		Biopharmaceuticals	$1	+57%	$13B	$12B	2.5x	8.8x
Regencell Bioscience		Biopharmaceuticals	$26	+3027%	$13B	$13B	—	—

Financial data powered by FactSet and Morningstar. Valuation multiples as of last 12 months. For more data, start your free trial here.

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.